CANCER GENOMICS: AN EDUCATIONAL SESSION AND METHODS WORKSHOP (Part 2)
Tracks
STREAM 2
Friday, November 5, 2021 |
12:00 PM - 3:30 PM |
STREAM 2 |
Speaker
Clayton Yates
Overview of genomics technologies and applications
Associate Professor And Scientific Director Melissa Davis
Weill Cornell Medicine
Clinical and translational genomics of breast cancer in Blacks
John Carpten
Clinical and translational genomics of prostate cancer in Blacks
Dr Sam Mbulaiteye
National Cancer Institute
Infections and genomic alteration in lymphoma in Africa
Akinyemi Ojesina
HPV and genomic drivers of cervical cancer in Africa
Dr. Jaclyn Goodrich
University of Michigan School of Public Health
ENVIRONMENTAL DETERMINANTS OF EPIGENOMIC ALTERATIONS IN CANCER
Abstract
In addition to genomic mutations, broad epigenomic alterations contribute to the development of every type of cancer. The epigenome consists of modifications to DNA and chromatin that do not alter the underlying DNA sequence yet are heritable across cell divisions and regulate gene expression. Epigenetic mechanisms include DNA methylation, posttranslational histone tail modifications, and non-coding RNA. Tumors exhibit epigenetic signatures that vary drastically from healthy tissue, and these signatures include the silencing of tumor-suppressor genes. Myriad environmental factors including metals, synthetic chemicals, stress, and more can alter the epigenome. This may be a mechanism by which environmental exposures contribute to the development of cancer. In this educational session, epigenomics and its role in carcinogenesis will be briefly introduced. Then, evidence for the impact of environmental exposures on the epigenome will be presented as it relates to cancer risk.
Facilitators
Hannah Naa Gogwe Ayettey Anie
National Radiotherapy Oncology and Nuclear Medicine Centre
Pedro Fernandez
Stellenbosch University
Solomon Rotimi
Covenant University